The Baltimore Ravens landed a two-time Pro Bowl center this week, acquiring Cam Jurgens from the Philadelphia Eagles in a trade that sent a 2028 second-round pick and a 2027 fifth-round pick to Philadelphia, with the Eagles sending back a 2027 seventh-round pick along with Jurgens. The move addresses one of the most dire positional crises in the league, but it comes bundled with real medical risk tied to the back injury that has dogged Jurgens since Super Bowl LIX.
Baltimore’s center room has been a disaster zone all season. The Ravens lost three-time Pro Bowler Tyler Linderbaum to the Las Vegas Raiders in free agency over the offseason, then watched Danny Pinter, the presumed replacement, suffer a season-ending torn patellar tendon in August. Jovaughn Gwyn stepped in to open the year before fracturing his fibula in Week 3, and backup Ethan Pocic went down with a significant knee injury in the same game in Brazil. That left first-round rookie Vega Ioane, a natural guard, scrambling to man the position out of necessity.
A Costly Fix With a Medical Red Flag
Jurgens, 27, has been Philadelphia’s primary center since Jason Kelce retired after the 2023 season and made the Pro Bowl in back-to-back years. He signed a four-year, $68 million extension with the Eagles in April 2025, and per OverTheCap.com, his $17 million average annual value makes him the fourth-highest-paid center in the league behind names like Creed Humphrey, Aaron Brewer and Linderbaum himself. The Eagles had already paid out his option bonus, so Baltimore is reportedly only on the hook for the remainder of his $1.2 million base salary this season, with $16 million fully guaranteed in 2027 and $17 million non-guaranteed in both 2028 and 2029.
The bigger story is the medical file attached to the deal. Jurgens underwent back surgery in the 2025 offseason to repair a herniated disc that had broken off and wrapped around his sciatic nerve during Philadelphia’s Super Bowl run, an injury he has said left him unable to fully train and never quite himself throughout last season. He also sought stem cell treatment this past offseason to aid the recovery. Because of that history, the Ravens took an unusual step before finalizing the trade: they sent their chief medical officer and head athletic trainer to the Eagles’ facility to put Jurgens through a physical on-site, rather than waiting for him to travel to Baltimore, a direct response to lessons learned from the Las Vegas Raiders’ failed Maxx Crosby trade physical. Jurgens passed, and the deal was announced only after Baltimore’s doctors signed off. He is currently in concussion protocol after reporting symptoms following Philadelphia’s Week 4 loss to the Rams, which will delay his on-field debut in Baltimore regardless of how the back holds up.
What the Betting Market Says About Baltimore’s Gamble
The trade lands at a strange moment for Ravens futures. Baltimore enters Week 5 at 3-1 and sitting at roughly +850 to win Super Bowl LXI and around +405 for the AFC, with Lamar Jackson’s ankle injury serving as the swing factor the market is watching most closely. Jackson has been ruled out for Sunday’s game at Atlanta and is targeting a Week 6 return against Cleveland. Despite that absence, Baltimore’s AFC North odds actually tightened after its Week 4 win over Tennessee, with the Ravens’ division price shortening from roughly 53% to 61% on one tracked market even as Jackson left the game. The team’s spread for the Atlanta matchup also moved from Ravens -6 down to -3.5 once the ankle injury and Jurgens’ absence from the lineup, still in concussion protocol, became apparent.
Investing a second-round pick in protecting the position in front of Jackson, even while he’s sidelined, signals the Ravens view their Super Bowl window as very much open and are willing to pay a premium to secure the interior line before Jackson returns. If Jurgens’ back holds up and he’s cleared from concussion protocol in time to anchor the line by the Cleveland game, Baltimore’s offensive line outlook improves considerably just as its franchise quarterback comes back into the fold, a scenario that would likely support continued stability or shortening in the Ravens’ division and conference futures. If the back issue resurfaces, however, Baltimore has now committed significant draft capital and guaranteed money to a question mark at a position that has already cost them three starters this season. Bettors watching Ravens futures over the next several weeks should treat Jurgens’ practice status and snap counts, once healthy, as a leading indicator for how the market adjusts Baltimore’s AFC North and conference odds heading into its Week 6 return window.
